Google has announced that the Food and Drug Administration (FDA) has cleared its product, Fitbit, to use a new feature that will identify atrial fibrillation (AFib). In a statement on Monday, Google said Fitbit’s new PPG AFib algorithm feature will assess user’s heart rhythm while they’re sleeping, adding that the new feature will alert users if they suffering from AFib. This will give them time to notify their healthcare provider about their diagnosis, Google said. AFib, often referred to as atrial fibrillation, is a form of an irregular heart rhythm that can be difficult to detect at first because there are no signs of symptoms. About 33.5 million people suffer from this heart c
Hence then, the article about fda clears fitbit for passive heart rhythm monitoring was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( FDA clears Fitbit for passive heart rhythm monitoring )